Cautionary Announcement – Aspen in Discussions with MSD
04 February 2013
By : Shauneen Beukes
Shareholders are advised that Aspen is currently engaged in discussions with MSD (known as Merck in the United States and Canada) in respect of a possible transaction comprising the acquisition of an active pharmaceutical ingredient facility situated primarily in the Netherlands and a related portfolio of pharmaceutical finished dose form products.
These discussions may have a material effect on the price of Aspen's securities if successfully concluded and accordingly shareholders are advised to exercise caution when dealing in the company's securities.
4 February 2013
Investec Bank Limited